Showing results (101-110 of 280) with videos related to
Sort By:
Pageof 28
Clinicoeconomics and Outcomes Research : CEOR|September 11, 2024
Homologous Recombination Repair Testing Patterns and Outcomes in mCRPC by Alteration Status and RaceMehmet Asim Bilen, Ibrahim Khilfeh, Carmine Rossi, et al.Targeted Oncology|May 21, 2025
Olaparib Monotherapy or in Combination with Abiraterone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and a BRCA MutationFred Saad, Andrew J Armstrong, Neal Shore, et al.Clinical Genitourinary Cancer|July 17, 2013
"Real world" treatment of metastatic renal cell carcinoma in a joint community-academic cohort: progression-free survival over three lines of therapyMichael R Harrison, Daniel J George, Mark S Walker, et al.Oncotarget|November 3, 2016
Recombinant oncolytic poliovirus, PVSRIPO, has potent cytotoxic and innate inflammatory effects, mediating therapy in human breast and prostate cancer xenograft modelsEda K Holl, Michael C Brown, David Boczkowski, et al.International Journal of Cancer|May 17, 2017
Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancerYanru Wang, Jennifer A Freedman, Hongliang Liu, et al.Clinical Genitourinary Cancer|February 15, 2020
Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United StatesDaniel J George, Oliver Sartor, Kurt Miller, et al.Journal for Immunotherapy of Cancer|September 14, 2021
Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumabLandon C Brown, Kunal Desai, Wei Wei, et al.JU Open Plus|September 16, 2024
Physician Perspectives on the Nonclinical Factors That Contribute to Decision-Making for Advanced Prostate Cancer Care: A Qualitative StudyDeborah R Kaye, Karissa Tu, J Kelly Davis, et al.Clinical Journal of Oncology Nursing|May 23, 2015
Optimizing the efficiency and quality of sipuleucel-T delivery in an academic institutionKristen Davis, Sarah Wood, Emily Dill, et al.European Urology Open Science|July 29, 2024
Design and Rationale of the Outcomes Database to Prospectively Assess the Changing Therapy Landscape in Renal Cell Carcinoma Registry: A Multi-institutional, Prospective Study of Patients with Metastatic Renal Cell CarcinomaNrupen A Bhavsar, Michael R Harrison, Charles D Scales, et al.Pageof 28